appears to protect against COVID-19 with just one shot — though not as strong as some two-shot rivals, it's still potentially helpful for a world in dire need of more doses.
Rocky Mountain Regional VA Medical Center investigational pharmacy technician Sara Berech prepares a dose of the Johnson & Johnson COVID-19 vaccine for a clinical trial on December 15, 2020 in Aurora, Colorado. "The level of protection against moderate and severe COVID-19 infection was 72 per cent in the US, 66 per cent in Latin America and 57 per cent in South Africa, 28 days post-vaccination."With vaccinations off to a rocky start globally, experts had been counting on a one-dose vaccine that would stretch scarce supplies and avoid the logistics nightmare of getting people to return for boosters.
Researchers tracked illnesses starting 28 days after vaccination – about the time when, if participants were getting a two-dose variety instead, they would have needed another shot.
Vaccine - substance used to stimulate the production of antibodies and provide immunity against one or several diseases, prepared from the causative agent of a disease, its products, or a synthetic substitute, treated to act as an antigen without inducing the disease.
This is where the government sexist approach to the Family Court shines, why it makes “sense” , by making women and children dependent on government they will submit to be vaccinated IF THEY WANT TO GET PAID.
Dont let the racist woke push legislation through for mandatory vaccine for indigenous and elderly, in the small print , its then by default legislated mandatory for you .